Floatz logo

Metformin

Chronic Stable Angina

Wake Forest University Health SciencesSmall moleculePhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Chronic Stable Angina cohort.

Asset / SponsorPhaseRating
Danhong
China Academy of Chinese Medical Sciences
Phase 4BB
MERCAPTOPURINE ANHYDROUS
Stephen McSwiggan
Phase 4BB
ATENOLOL
Ferozsons Laboratories Ltd.
Phase 4BB
Nicorandil
Ferozsons Laboratories Ltd.
Phase 4BB
METHOTREXATE
Stephen McSwiggan
Phase 4BB

View all 18 →

Same molecule, other indications

Metformin is also rated in:

Metabolism and Nutrition DisorderDormant
A
Indicative ·
82 / 100
View asset →
prediabetes syndromeDormant
A
Indicative ·
81 / 100
View asset →
gestational diabetesDormant
A
Indicative ·
81 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →